Literature DB >> 11161909

Clinical, public health, and research implications of the Heart Outcomes Prevention Evaluation (HOPE) Study.

S Yusuf.   

Abstract

Mesh：

Substances：

Year:  2001        PMID： 11161909     DOI： 10.1053/euhj.2000.2459

Source DB:  PubMed          Journal:  Eur Heart J        ISSN： 0195-668X            Impact factor:   29.983


× No keyword cloud information.
  4 in total

1.  Management of Diabetes with Coronary Artery Disease.

Authors:  Michelle Fischmann Magee; Adeyinka A Taiwo; Barbara Viventi Howard
Journal:  Curr Treat Options Cardiovasc Med       Date:  2003-02

Review 2.  Pathogenesis and treatment of atherosclerosis in lupus.

Authors:  Maureen McMahon; Brian Skaggs
Journal:  Rheum Dis Clin North Am       Date:  2014-06-10       Impact factor: 2.670

Review 3.  Ramipril: a review of its use in the prevention of cardiovascular outcomes.

Authors:  Gregory T Warner; Caroline M Perry
Journal:  Drugs       Date:  2002       Impact factor: 9.546

4.  How long should angiotensin-converting enzyme inhibitors be given to patients following myocardial infarction: implications of the HOPE trial.

Authors:  Vernon VS Bonarjee; Kenneth Dickstein
Journal:  Curr Control Trials Cardiovasc Med       Date:  2001
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.